James King, MBA

Board Member

James King spent over 20 years as an institutional investor in public healthcare companies. He is passionate about the complexities and innovation in healthcare and was initially exposed to the Minneapolis Heart Institute Foundation when he spoke with MHI cardiologists while conducting research on clinical stage transcatheter aortic heart valves. He decided to become a board member at MHIF due to his mother who continues to battle vascular disease, and after his father passed away from a stroke in 2020.

James received his BS from University of Wisconsin and his MBA from University of Minnesota.

Back to Board of Directors

Give the Gift of Hope

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.